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Abstract
Objective
To evaluate the effectiveness of telephone health 
coaching delivered by a nurse to support self 
management in a primary care population with mild 
symptoms of chronic obstructive pulmonary disease 
(COPD).
Design
Multicentre randomised controlled trial.
Setting
71 general practices in four areas of England.
Participants
577 patients with Medical Research Council dyspnoea 
scale scores of 1 or 2, recruited from primary care 
COPD registers with spirometry confirmed diagnosis. 
Patients were randomised to telephone health 
coaching (n=289) or usual care (n=288).
Interventions
Telephone health coaching intervention delivered 
by nurses, underpinned by Social Cognitive Theory. 
The coaching promoted accessing smoking cessation 
services, increasing physical activity, medication 
management, and action planning (4 sessions over 11 
weeks; postal information at weeks 16 and 24). The 
nurses received two days of training. The usual care 
group received a leaflet about COPD.
Main outcome measures
The primary outcome was health related quality of 
life at 12 months using the short version of the St 
George’s Respiratory Questionnaire (SGRQ-C).
Results
The intervention was delivered with good fidelity: 86% 
of scheduled calls were delivered; 75% of patients 
received all four calls. 92% of patients were followed-
up at six months and 89% at 12 months. There was no 
difference in SGRQ-C total score at 12 months (mean 
difference −1.3, 95% confidence interval −3.6 to 0.9, 
P=0.23). Compared with patients in the usual care 
group, at six months follow-up, the intervention group 
reported greater physical activity, more had received 
a care plan (44% v 30%), rescue packs of antibiotics 
(37% v 29%), and inhaler use technique check (68% 
v 55%).
Conclusions
A new telephone health coaching intervention to 
promote behaviour change in primary care patients 
with mild symptoms of dyspnoea did lead to changes 
in self management activities, but did not improve 
health related quality of life.
Trial registration
Current controlled trials ISRCTN 06710391
Introduction
Chronic diseases, such as chronic obstructive 
pulmonary disease (COPD), are a major cause of death 
and disability in high income countries and of rising 
importance in low and middle income countries.1 
Owing to their high prevalence and chronicity, current 
international policy focuses on the need to support 
patients to self manage their conditions.2 Most 
interventions designed to support self management 
have been targeted at people with more severe disease 
who are likely to be motivated to change behaviour, and 
where there is the most opportunity for symptomatic 
improvement. However, more recent efforts have 
aimed to prevent onset or slow progression early in 
the disease course to reduce the burden and costs of 
treating more advanced disease later. This prevention 
model has only recently been adopted in COPD, with 
calls for interventions to reduce risk in people with 
early disease.3
The growing number of people at risk of developing 
long term conditions and the prevalence of early 
disease, means an accessible and low resource approach 
needs to be taken to support self management. One 
such approach is to use interactive telephone health 
coaching, with the coach and patient working together 
to identify barriers to behaviour change and finding 
ways to overcome them. Key techniques include 
modelling behaviour, goal setting, and empowering 
the patient to improve their health status.4 Telephone 
health coaching has shown potential benefits on self 
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WhAt Is AlreAdy knoWn on thIs topIc
Current policy for the prevention and management of long term conditions 
focusses on efforts to prevent onset or slow progression of disease early in the 
disease trajectory
This prevention paradigm has only recently been adopted for chronic obstructive 
pulmonary disease (COPD)
Systematic reviews have shown that self management support for patients with 
COPD is effective in improving health related quality of life and in reducing 
hospital admissions, but the evidence comes largely from patients with 
moderate or severe disease and predominantly recruited from secondary care
WhAt thIs study Adds
Telephone health coaching comprising components that were theoretically 
associated with slowing decline of lung function, did improve self management 
activities that were targeted by the intervention in patients with mildly 
symptomatic COPD recruited from primary care
Health related quality of life was not improved over the 12 month follow-up 
period
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efficacy, health behaviour, and health status in a rapid 
review of trials in long term conditions.5
COPD is a common respiratory condition with an 
estimated 65 million people worldwide with moderate 
or severe disease.1 Like most chronic diseases, it causes 
a considerable burden on health services and society 
and is a leading cause of death in most countries.6 7 
Interventions to support self management in patients 
with COPD have been shown to be effective in 
improving health related quality of life and in reducing 
hospital admissions among patients with COPD,8 9 but 
trials have largely recruited people from secondary 
care and excluded those with mild disease.9 However, 
patients with mild dyspnoea represent 38% to 54% of 
diagnosed patients in primary care.10 11 This is likely to 
increase with case finding initiatives to identify disease 
in people with symptoms.12
Many components of self management interventions 
could promote better health and prevent disease 
progression in the early stages of COPD. Smoking is 
a major cause of COPD, and smoking cessation has 
been shown to be beneficial in maintaining better lung 
function and in slowing disease progression across all 
severity levels.13 14 Reduced physical activity level is 
an independent risk factor for exacerbations, hospital 
stays, and mortality among those with COPD and 
occurs even in the early stages of disease.15-17 Inhaler 
treatments have well established efficacy in reducing 
exacerbations and admissions among patients with 
moderate and severe COPD, and growing evidence of 
efficacy in improving clinical outcomes and reducing 
decline in lung function among patients with more 
mild impairment.18 19 Any intervention that improves 
medication adherence and inhaler use technique, 
which is frequently poor,20 is thus likely to improve 
outcomes for patients. Sixty per cent of primary care 
patients with COPD report exacerbations of their 
disease,10 which are associated with more rapid decline 
in lung function.14 Interventions that aim to reduce 
the severity of exacerbations include prompting early 
recognition of symptoms and rapid use of antibiotics 
or corticosteroids, or both, either through seeking a 
primary care appointment or use of a self treatment 
rescue drug pack.
We evaluated telephone health coaching in patients 
with mildly symptomatic COPD to explore the 
effectiveness of supporting self management activities 
in this group of patients. We hypothesised that a 
telephone health coaching intervention delivered by 
a nurse to support self management, compared with 
usual primary care, would lead to improved COPD 
health related quality of life at 12 months follow-
up and would improve physical activity, smoking 
cessation, self management behaviours, psychological 
health, and self efficacy.
Methods
Design
Patient self management for chronic obstructive 
pulmonary disease (COPD) was a pragmatic 
multicentre phase III randomised controlled trial 
(RCT) of a telephone health coaching intervention to 
support self management compared with usual care 
for people with COPD with mild dyspnoea. Details of 
the study protocol have been published elsewhere.21 
We followed the CONSORT guidelines for reporting 
RCTs of non-pharmacological treatments to report this 
study.22 After publication of the protocol in the ISRCTN 
clinical trial registry at the feasibility study phase, we 
changed the inclusion criterion for post-bronchodilator 
spirometry from below the lower limit of normal to 
forced expiratory volume in one second/forced vital 
capacity <0.7, which is that recommended by the 
Global Initiative for Obstructive Lung Disease (GOLD).6 
We also included some additional subgroup analyses 
to those in the published protocol (baseline forced 
expiratory volume in one second predicted (≥80 or <80) 
and degree of limitation of activities in the St George’s 
Respiratory Questionnaire (SGRQ-C)).21 We embedded 
a substudy that investigated participant recruitment 
materials. In this substudy, general practices were 
randomised to send out either the standard participant 
information leaflet or a participant information leaflet 
which contained an additional web address and Quick 
Response code to give access to web-based materials 
including podcasts about taking part in research in 
general and in the patient self management COPD 
trial in particular.23 This did not alter any other trial 
processes.
Participants
Participants were recruited from 71 general practices 
within England located in Birmingham and West 
Midlands South, Greater Manchester, West Midlands 
North, and Oxfordshire or Gloucestershire. Patients 
aged over 18 were identified as eligible if they were 
on the practice COPD register, thus had respiratory 
symptoms consistent with COPD; reported mild 
dyspnoea (MRC grades 1 (only breathless on strenuous 
exercise) or 2 (only get short of breath when hurrying 
on level ground or up a slight hill)) at the baseline 
assessment; had a forced expiratory volume in 
one second/forced vital capacity <0.7 after post-
bronchodilator spirometry (consistent with current UK 
guidelines)24 at the baseline assessment. If there was a 
contraindication or the patient was unable to perform 
or refused spirometry, a spirometry result reported from 
hospital within the last 18 months was used. Doctors 
were asked to exclude patients who they considered 
to be inappropriate for the study (eg, had a terminal 
disease or a severe psychiatric disorder). Eligible 
patients were sent a letter of invitation, information 
brochure, and information leaflet from their practice, 
with a reply slip to the research team which included 
the MRC dyspnoea scale. Patients with MRC grade 1 or 
2, and those without a recorded dyspnoea score were 
invited to participate.
Baseline assessment
Patients who expressed an interest in the study were 
telephoned by a researcher and invited to a recruitment 
assessment at their practice, undertaken by a research 
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nurse or trained researcher. Patients who attended 
baseline assessments were given the opportunity 
to discuss the study. After informed consent, post-
bronchodilator spirometry was undertaken, height 
and weight were measured, and the patient was 
asked to complete a baseline questionnaire pack. This 
questionnaire pack included questions on patient 
demographics and the measures for the primary and 
secondary outcomes. A GENEActiv accelerometer was 
fitted on their non-dominant wrist, which they were 
asked to return by post in a prepaid envelope after 
seven days of continuous wear.
Intervention and usual care
This was a pragmatic trial with no constraints on 
doctors’ management of the participants in either 
group.
The usual care group received a standard 
information leaflet about self management of COPD.25 
The 13 page leaflet gave a definition of COPD, a 
detailed description of associated symptoms, how the 
illness can be managed with the use of inhalers, how to 
treat exacerbations, and details of other resources (eg, 
British Lung Foundation and NHS Smokefree).
The intervention consisted of telephone health 
coaching delivered by a nurse with supporting written 
documents, a pedometer, and a self monitoring diary. 
This aimed to support self management in relation to 
smoking cessation, physical activity increases, correct 
inhaler use technique, and medication adherence. 
For those with recurrent exacerbations, it also aimed 
to improve patient confidence in identifying an 
exacerbation early in order to start rescue drugs (ie, 
antibiotics or steroids).
Social Cognitive Theory underpinned the 
intervention,26 and included education, monitoring, 
and assessment of progress, and taught skills with the 
aim of increasing self efficacy.27 28 We incorporated 
best evidence for the promotion of physical activity 
(tailored, ongoing support, duration six months, use 
of pedometer).29-32 The intervention components 
are detailed in web appendix 1. The first telephone 
coaching session at one week after randomisation 
aimed to last 35-60 minutes (determined by the 
number of issues requiring discussion, such as current 
smoking), followed by a 15-20 minute telephone 
session at weeks 3, 7, and 11 with written supportive 
materials tailored to the patient after each telephone 
call (eg, summary of goals agreed, physical activity 
diary, contact details for local services, information 
leaflet showing correct inhaler use technique). Nurses 
provided standard written prompts or information at 
weeks 16 and 24.
The eight nurses attended two days of training 
and practiced telephone coaching sessions with the 
research team. Nurses followed a proforma to guide 
the consultation in accordance with the telephone 
consultation protocol. The nurses briefly summarised 
the content of the call and any actions agreed after each 
telephone call. A sample of telephone consultations 
were recorded with the patients consent and reviewed 
by one researcher to determine compliance with the 
content of the intervention.
Randomisation and masking
Patients who had given informed consent and completed 
all the baseline measures were individually randomised 
in a 1:1 ratio to the telephone health coaching or usual 
care group stratified by centre. The allocation was made 
using a web-based programme hosted by the Primary 
Care Clinical Research and Trials Unit, University 
of Birmingham. Centre specific randomisation lists 
were produced by a statistician at the trials unit. The 
four recruitment centres were Birmingham and West 
Midlands South, Greater Manchester, West Midlands 
North, and Oxfordshire or Gloucestershire. Only the 
Primary Care Clinical Research and Trials Unit had 
access to the allocation sequence. Patients were 
informed of their allocation at the end of the recruitment 
appointment; they were not masked to treatment 
allocation. Data were entered into the study database by 
researchers at the University of Birmingham who were 
masked to the treatment allocation.
Outcome assessment
We measured outcomes by postal questionnaire at 
six months to determine short term change to the end 
of the intervention and at 12 months to determine 
whether any change was sustained. At 12 months, 
accelerometers were posted to participants with a 
follow-up telephone call to explain how to start the 
recording. They were asked to wear the accelerometers 
continuously for seven days and then to return them 
by post. Non-responders were telephoned and given 
the option of completing the questionnaire over the 
telephone.
Outcomes
The primary outcome measure was health related 
quality of life at 12 months from randomisation 
measured using the SGRQ-C.33 Scores range from 0 to 
100, with higher scores indicating greater impairment 
of quality of life.
Secondary outcomes were the MRC dyspnoea scale,34 
self reported physical activity (using the International 
Physical Activity Questionnaire),35 psychological 
morbidity (using the Hospital Anxiety and Depression 
Scale),36 self efficacy for managing their COPD and 
undertaking physical activity (using the Stanford 
self efficacy scale),28 and health state utility (using 
the EuroQoL 5 Dimensions 5 Levels)37 at six and 12 
months from randomisation. Health related quality of 
life at six months from randomisation measured using 
the SGRQ-C was also a secondary outcome. Smoking 
cessation rates and physical activity measured with 
GENEActiv accelerometers were assessed at 12 
months. Prespecified exploratory outcomes were self 
management activities (related to smoking cessation, 
medication adherence, care plans, etc) reported by the 
patients and healthcare use at six and 12 months. An 
economic evaluation has also been undertaken, but 
will be reported elsewhere.
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Adverse events were reported by intervention 
participants during telephone calls and from the six 
and 12 month follow-up questionnaires; they were 
independently assessed by two independent clinicians.
Statistical justification for sample size
The sample size was determined to detect a difference 
in the SGRQ-C at 12 months. To have 80% power to 
detect a difference of four points (the minimal clinically 
significant difference)38 from a baseline total score 
value of 39,39 with a standard deviation of 15 at the 5% 
level of significance required data from 445 patients. 
Allowing for an attrition rate of 20% at 12 months, we 
needed 556 participants (278 for each group).
The power to detect differences in self reported 
physical activity and in smoking cessation rates are 
detailed in the protocol paper.21
Analysis
All data were analysed by intention to treat. The main 
analyses compared primary and secondary outcome 
measures between treatment groups at 12 months after 
randomisation to assess the long term effect of the self 
management intervention. Data were also analysed at 
six months to assess the short term change.
The primary outcome and other continuous 
secondary outcome measures were analysed using a 
linear regression model. Ordered categorical secondary 
outcome measures (eg, MRC dyspnoea scale) were 
analysed using an ordinal logistic regression model. 
All primary and secondary analyses were adjusted 
for baseline values and centre. Differences between 
treatment groups were summarised using suitable 
effect estimates (eg, mean difference and odds ratio) 
with 95% confidence intervals. We used a 5% statistical 
significance level.
Exploratory outcome measures were not analysed 
using statistical modelling except for the count data. 
Binary or categorical outcome measures were analysed 
using χ2 or Fisher’s exact test and continuous measures 
were analysed using t-tests or a non-parametric 
equivalent (eg, Wilcoxon rank test). Measures of count 
were analysed using a Poisson regression model or 
negative binomial model as appropriate to obtain an 
incidence rate ratio. Models included an adjustment 
for baseline values and centre and an offset term for 
length of follow-up.
Several sensitivity analyses were performed for 
the SGRQ-C. Firstly, a per-protocol analysis which 
included only those patients who received all four 
telephone calls in the intervention group and excluded 
the one patient in the usual care group who received 
the intervention by mistake. Secondly, an analysis to 
assess the effect of missing data, with patients with 
missing 12 month SGRQ-C scores being simulated 
by regression imputation using baseline data, with 
baseline score, age, sex, MRC score, and treatment 
group used as predictors to impute missing scores. 
All participants were included in this analysis unless 
they had died by 12 months or both the baseline and 
12 month SGRQ-C scores were missing. Finally, an 
analysis which excluded participants where the 12 
month SGRQ-C questionnaires were returned either 
early (>1 month before the assessment due date) or late 
(>65 days after the assessment due date).
Subgroup analyses to explore the effects of the 
intervention in different patient subgroups were 
undertaken for the primary outcome. The subgroups, 
prespecified in the statistical analysis plan included 
participant characteristics (age, sex, ethnicity, 
smoking status, baseline MRC dyspnoea score, and 
number of comorbidities), active engagers with the 
intervention (through increased physical activity, 
uptake of smoking cessation support, or checking 
of inhaler use technique), baseline level of physical 
activity (from both the International Physical Activity 
Questionnaire and the accelerometer data), baseline 
health related quality of life (SGRQ-C), baseline self 
efficacy (Stanford), and baseline depression and 
anxiety (from the Hospital Anxiety and Depression 
Scale). Two post hoc subgroup analyses were also 
undertaken for baseline forced expiratory volume 
in one second predicted (≥80 or <80) and degree of 
limitation of activities in the SGRQ-C. A treatment 
group by subgroup interaction parameter was included 
in the linear regression model to assess whether there 
were any differences in the treatment effect across the 
different strata. Differences between treatment groups 
within subgroups were only examined if the interaction 
parameters were statistically significant (P<0.05).
Details of the accelerometery analyses and available 
accelerometry data are provided in web appendix 2.
Patient involvement
The study was supported by a COPD patient advisory 
group which provided input to a programme of research 
on COPD. The group met on a regular basis and one was a 
member of the trial management group for the duration 
of the study. The group commented on the initial design 
of the study, the burden of the trial assessment process, 
participant facing materials, and on the content and 
material to support the intervention. Additionally, the 
Trial Steering Group had a lay member. At the end of 
the study, the group commented on the findings and 
contributed to the dissemination plan.
results
We sent a screening questionnaire and invitation 
leaflet to 5279 people on the COPD registers of 71 
general practices; 2066 responded with an interest 
in the study, but 920 were excluded as they had an 
MRC dyspnoea scale score of 3 or more. Figure 1 
shows that we screened 728 people at their practice 
between 18 March 2014 and 5 February 2015; 577 
were eligible and randomised to telephone health 
coaching (n=289) or usual care (n=288). In total, 531 
(92%) of participants provided data at six months 
and 516 (89%) at 12 months follow-up. There was 
imbalance in the follow-up rates between telephone 
health coaching (82.7%; 37 withdrawals) and usual 
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care (96.2%; 7 withdrawals) groups at 12 months, 
largely owing to patients who wished to withdraw from 
telephone health coaching also withdrawing from 
further follow-up. Of the 37 patients who withdrew 
from the telephone health coaching group, four 
withdrew before receiving any intervention and 16 
withdrew during the intervention; eight cited illness 
and 10 cited intervention related factors ranging from 
it being too demanding to insufficiently so. Seventeen 
participants withdrew after the six months follow-up. 
Patients who withdrew from the study did not differ in 
characteristics to the full sample.
Table 1 shows the patient characteristics. Participants 
were predominantly white; 63% were male; the mean 
age was 70.4; 23% were current smokers; and only 
19% were in paid employment. Participants had mild 
disease: mean FEV1 was 71.6% predicted, 193 (33%) 
were GOLD stage 1 and 309 (54%) GOLD stage 2; 
165 (28.6%) reported MRC level I dyspnoea and 270 
(47%) reported medication for an exacerbation in the 
previous 12 months. The mean SGRQ-C total score was 
28.7. The study groups were generally well balanced in 
terms of patient characteristics, although there was a 
higher proportion of current smokers in the telephone 
health coaching group. The usual care group reported 
a higher level of self reported moderate and vigorous 
physical activity, but this was not reflected in the 
accelerometry data at baseline. The accelerometry 
data for all participants showed that participants did a 
median of 31 minutes of moderate or vigorous activity 
in bouts of at least 10 minutes daily (interquartile 
range 0-160). Participants who did not provide data at 
12 months were more likely to be in GOLD stage 3, to 
be smokers, had lower levels of self reported physical 
activity, and to live alone than responders.
Intervention delivery
The dose and coverage of intervention delivery was 
high: 86.4% (999/1156) of the scheduled calls were 
delivered and 75.4% (218/289) of participants 
received all four calls. The average duration of calls 
was 39.2 minutes (SD 10.7) for the first call, then 23.8 
Usual care (n=288)Telephone health coaching (n=289)
No of participants identied (n=6498)
No of invitations sent (n=5279)
No of responses received (n=2066)
Eligible (n=1146)
Consented (n=728)
Randomised (n=577)
Received usual care (n=287)
Received telephone health coaching in error
(completed 3 telephone calls and
received written prompts) (n=1)
Received telephone health coaching (n=285)
Participants withdrew from telephone
health coaching part-way through intervention
but agreed to continue follow-up (n=23)
6 months follow-up (n=287)
Forms returned (n=283)
Contributed to primary outcome (n=225)
Forms not returned or returned blank (n=4)
6 months follow-up (n=267)
Forms returned (n=248)
Contributed to primary outcome (n=214)
Forms not returned or returned blank (n=19)
Ineligible due to MRC >2 (n=920)
Ineligible at clinic assessment (n=151)
Unable to contact or unable to
book baseline clinic appointment or
responded outside recruitment (n=418)
Withdrawn (n=1)
Died (n=0)
Withdrawn (n=20)
Died (n=2)
12 months follow-up (n=281)
Forms returned (n=277)
Contributed to primary outcome (n=242)
Forms not returned or returned blank (n=4)
12 months follow-up (n=247)
Forms returned (n=239)
Contributed to primary outcome (n=211)
Forms not returned or returned blank (n=8)
Withdrawn (n=6)
Died (n=0)
Withdrawn (n=17)
Died (n=3)
Fig 1 | Study flow diagram
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Table 1 Baseline patient characteristics. Values are numbers (percentages) unless stated otherwise
Characteristic Telephone health coaching (n=289) Usual care (n=288)
Mean (SD) age (years) 70.7 (8.8) 70.2 (7.8)
Age ≥65 years 221 (76) 231 (80)
Men 183 (63) 183 (64)
White race 283 (98) 284 (99)
Median (interquartile range) age at completion of full time 
education (years)* 
15 (15-16) 15 (15-16) 
Highest level of qualification:
 No formal qualification 128 (44) 135 (47)
 GCSE, CSE, O Level equivalent 58 (20) 63 (22)
 A Level, AS Level, or equivalent 27 (9) 24 (8)
 Degree level or higher 35 (12) 41 (14)
 Other 40 (14) 23 (8)
 Missing 1 (<1) 2 (1)
Lives alone 83 (29) 69 (24)
Employment status†: 
 Paid work 58 (20) 53 (18)
 Unemployed or looking for work 3 (1) 5 (2)
 Retired from paid work 216 (75) 214 (74)
 Looking after family or home 8 (3) 9 (3)
 Unable to work owing to health problems 8 (3) 7 (2)
 Other 5 (2) 9 (3)
Clinical characteristics 
Current smoker 75 (26) 55 (19)
Mean (SD) body mass index (kg/m2) 27.1 (4.4) 27.4 (4.9)
MRC dyspnoea scale score:
 1 89 (31) 76 (26)
 2 200 (69) 212 (74)
Mean (SD) FEV1 predicted (%) 71.2 (18.9) 72.1 (18.7)
FEV1 predicted (%):
 <30 1 (<1) 2 (1)
 30-49 39 (13) 33 (11)
 50-79 160 (55) 149 (52)
 ≥80 89 (31) 104 (36)
Comorbidities:
 Cancer 34 (12) 37 (13)
 Diabetes 32 (11) 36 (13)
 High blood pressure 135 (47) 123 (43)
 Coronary heart disease 34 (12) 44 (15)
 Heart failure 15 (5) 10 (3)
 Stroke or mini-stroke 16 (6) 25 (9)
 Asthma 98 (34) 100 (35)
 Tuberculosis 6 (2) 10 (3)
 Osteoarthritis 46 (16) 56 (19)
 Rheumatoid arthritis 22 (8) 25 (9)
 Osteoporosis 13 (5) 20 (7)
 Depression 44 (15) 57 (20)
 Other condition 37 (13) 52 (18)
(Continued)
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(9.2), 21.4 (8.6), and 20.6 minutes (8.7) for the second, 
third, and final calls respectively. Nurses briefly noted 
the content and duration of each telephone health 
coaching session. Most patients spoke to the same 
nurse for all four calls, although sometimes this 
was not possible owing to illness or leave. Smoking 
was discussed in 33% of sessions, physical activity 
in over 99%, inhaler use technique in 90%, and 
action planning in 88% of all calls. SMART (specific, 
measurable, achievable, relevant, and time bound) 
goals were set in 57% of calls for physical activity, in 
11% for smoking cessation, and in 9% for inhaler use 
technique to be checked.
Primary outcome
At 12 months, there was no significant difference in 
the total SGRQ-C score (mean difference −1.3, 95% 
confidence interval −3.6 to 0.9, P=0.23), although 
the direction favoured the intervention group. The 
mean difference in the SGRQ-C activity score was of 
borderline significance favouring the intervention 
group (−3.2, −6.3 to 0.0, P=0.05). Table 2 shows that 
there was no significant difference between groups for 
the SGRQ-C symptoms or impact scores.
Secondary outcomes
Table 2 shows that at six months, there were no 
significant differences in the SGRQ-C total and 
subscores. At six and 12 months, there were also no 
differences in the EuroQoL 5 Dimensions 5 Levels, 
Hospital Anxiety and Depression Scale, Stanford self 
efficacy scale, or level of breathlessness (MRC, table 
3). At six months, total self reported physical activity, 
walking, moderate, and vigorous intensity activity 
were all significantly higher in the intervention arm 
(table 2). Differences favoured the intervention arm 
at 12 months, but they did not remain statistically 
significant. There was no difference in moderate or 
vigorous activity measured using accelerometry at 
12 months. There was also no difference in smoking 
cessation rates at six and 12 months (table 3).
Healthcare utilisation
At six months, intervention participants reported 
lower doctor and pharmacist consultations, but higher 
all cause emergency department visits. There were 
no differences at 12 months (table 4). At six and 12 
months, 106 (43%) and 89 (37%) of the intervention 
group respectively had been prescribed at least one 
Table 1 Baseline patient characteristics. Values are numbers (percentages) unless stated otherwise
Characteristic Telephone health coaching (n=289) Usual care (n=288)
Medication taken regularly for lung problems:
 Beta-2 agonist 201 (70) 197 (68)
 Inhaled steroid 27 (9) 39 (14)
 Atrovent or Spiriva 109 (38) 117 (41)
 Seretide 88 (30) 92 (32)
 Symbicort 33 (11) 21 (7)
 Theophylline or aminophylline tablets 7 (2) 6 (2)
 Steroid tablets 5 (2) 9 (3)
Antibiotic or steroid course, or both, in past 12 months 135 (47) 135 (47)
Health related quality of life 
Mean (SD) SGRQ-C total score 27.8 (14.6) 29.5 (14.5)
Mean (SD) SGRQ-C symptoms score 48.5 (21.7) 47.9 (20.7)
Mean (SD) SGRQ-C activity score 36.3 (21.0) 38.7 (21.3)
Mean (SD) SGRQ-C impact score 15.4 (13.4) 17.6 (13.9)
Mean (SD) EuroQoL 5 Dimensions 5 Levels score 0.90 (0.13) 0.89 (0.13)
Anxiety and depression‡
Mean (SD) anxiety subscale score 3.8 (3.4) 4.3 (3.8)
Mean (SD) depression subscale score 2.9 (2.6) 3.1 (2.8)
Physical activity 
Mean (SD) minutes of MVPA/week by accelerometry 372.1 (305.1) 379.1 (282.9)
Mean (SD) moderate MET minutes/week§ 766.4 (1253.9) 941.5 (1437.6)
Mean (SD) vigorous MET minutes /week§ 809.4 (1771.5) 910.2 (1997.4)
Self efficacy 
Mean (SD) Stanford self efficacy score 8.3 (1.6) 8.0 (1.7)
FEV1=forced expiratory volume in one second; SGRQ-C=St George’s Respiratory Questionnaire; MVPA=moderate to vigorous physical activity; 
MET=metabolic equivalent.
* One subject in the telephone health coaching group never went to school.
† Not mutually exclusive, participants could tick all that applied.
‡ Using the Hospital Anxiety and Depression Scale.
§ Using the International Physical Activity Questionnaire.
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course of antibiotics compared with 105 (37%) and 96 
(35%) of the usual care group (data not shown).
Activities targeted by telephone health coaching
Physical activity and smoking cessation rates have been 
described previously. There was no difference between 
the groups in smoking quit attempts in the previous six 
months or attendance at smoking cessation services at 
either follow-up point. At six months, participants in 
the intervention group reported improved medication 
adherence, with significantly higher proportions 
having an inhaler check in the past six months 
(68% v 55%), an agreed care plan with a healthcare 
provider (44% v 30%), written advice about what to 
do if symptoms worsened (23% v 17%), and having 
an antibiotic rescue pack (37% v 29%). However, they 
did not report improved confidence in the use of rescue 
packs. Table 5 shows that many of these improvements 
were sustained at 12 months.
Sensitivity and subgroup analyses
There were no differences in the findings for the 
analysis in accordance with the protocol, when 
regression imputation was used to impute missing 
data, or when the analysis excluded questionnaires 
returned either early or late (see web appendix 3). 
Subgroup analyses also found no evidence that the 
effect size differed by age, sex, ethnicity, comorbidities, 
baseline MRC level, smoking status, Hospital Anxiety 
and Depression Scale, physical activity, predicted 
forced expiratory volume in one second (≥80 or <80), 
degree of limitation of activities in the SGRQ-C, active 
engagers, or self efficacy. There was some evidence of 
an interaction with baseline SGRQ-C (P=0.04); with a 
greater benefit for intervention in participants with a 
baseline score≥25 (ie, those with poorer quality of life) 
(mean difference −3.0, 95% confidence interval −6.4 
to 0.3) compared with those with a baseline score<25 
(2.3, −1.6 to 6.2).
Adverse events
There were 44 serious adverse events reported by 
participants; 24 in the telephone health coaching arm 
and 20 in the usual care arm. Five deaths occurred in 
the intervention group due to cor pulmonale, stroke, 
ruptured aortic aneurysm, and malignancy (2). None 
were considered to be related to the intervention.
discussion
Principal findings
This trial is the first to evaluate the effectiveness of a 
telephone health coaching intervention delivered by 
a nurse to support self management for patients with 
mild symptoms of chronic obstructive pulmonary 
disease (COPD). We showed an improvement in self 
reported self management activities in the telephone 
health coaching group compared with usual care, but 
we did not observe a difference in our primary outcome 
of health related quality of life measured by the St 
George’s Respiratory Questionnaire (SGRQ-C) (nor in 
the impact, symptom, or activity domains) although T
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the confidence intervals did include the minimal 
clinically important difference of four points for the 
activity and symptom domains. Self reported physical 
activity was higher at six months in the intervention 
group, but this was not sustained at 12 months. 
In addition, activities targeted by the intervention, 
including patients asking a health care professional to 
check their inhaler use technique, asking their doctor 
to agree a care plan, and having a rescue pack were 
higher in the intervention group at six and 12 months 
follow-up, compared with usual care. This suggested 
that a proportion of intervention participants adopted 
active self management.
Comparison with other studies
Our approach was new in comparison to other 
trials of self management and telephone coaching 
interventions by targeting patients with mildly 
symptomatic disease. Most previous trials of COPD 
self management have excluded participants with 
Global Initiative for Obstructive Lung Disease (GOLD) 
stage I (mild airflow obstruction),9 40 whereas a third of 
our patients, were in this category, as we particularly 
wanted to evaluate an intervention for patients with 
mild COPD, who are a clinically important, but largely 
neglected group despite having a reduced health 
related quality of life.41
Systematic reviews of self management interventions 
have reported improvements in COPD related quality 
of life, measured by the SGRQ with a mean difference 
of −2.40 at 12 months follow-up.9 40 42 All reviews 
reported effects larger than the −1.3 points difference 
at 12 months found in our trial. Health related quality 
of life has been favoured as the main outcome for 
trials of COPD self management as functional status is 
important to patients and is sensitive to change, while 
lung function has a natural variation making it difficult 
to interpret change over short follow-up periods. 
Compared with other studies of self management in 
COPD, even those in milder populations,39 the SGRQ-C 
total score in our study was very low at baseline 
(representing a good health related quality of life). 
This potentially led to a floor effect, where change 
may be unlikely to be achievable, or improvement 
may only be observed over a much longer period. 
However, for the activity subscore of the SGRQ-C, the 
mean difference at 12 months (−3.2) found in our trial 
compares well with those of the systematic reviews, 
which report statistically significant mean differences 
of −2.75 and −2.21.9 40 These findings are consistent 
with the differences found at six months (at the end 
of the patient self management COPD intervention) in 
self reported physical activity (International Physical 
Activity Questionnaire). However, this result of reduced 
limitations to physical activities was not reflected in the 
self reported quantity or intensity of physical activity 
(International Physical Activity Questionnaire) or our 
objective measures of physical activity where there 
were no differences between groups at 12 months.
An Australian randomised controlled trial (RCT) 
of a 12 month intensive telephone health mentoring T
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intervention for patients with moderate to severe 
COPD in primary care also did not report a difference 
in the SGRQ at 12 months; but did achieve greater 
improvements in self management capacity and 
in COPD knowledge than usual care.43 Similar to 
our trial, a 12 week RCT of an intensive automated 
telecoaching programme reported improvements in 
physical activity and the functional domain of the 
Clinical COPD Questionnaire, but not health related 
quality of life (COPD Assessment Test) at the end of 
the 12 week intervention period.44 Conversely, an 
RCT of telephone mentoring for home based walking 
showed no benefit in exercise capacity in patients with 
COPD before commencing a pulmonary rehabilitation 
programme, and also had a high withdrawal rate.45 In 
keeping with our findings, a rapid review of 30 RCTs 
of the effects of telephone health coaching to support 
self management of long term conditions reported 
improvements in health behaviours, but did not find 
conclusive evidence of improvements in quality of life.5
Observed short term improvements in self reported 
physical activity may have required a longer duration 
of support or intermittent maintenance activities to 
sustain changes. Primary care consultations were also 
lower in the intervention group at six months, which 
again may reflect the increased telephone contact in 
this period. A consistent message of the telephone 
health coaching was for intervention participants to 
use their routine appointments with primary care for 
their inhaler use technique to be checked or to discuss 
a care or action plan and it appears that participants 
heeded this message and did not book additional 
consultations for self management advice or support.
Strengths and limitations of this study
There were many strengths of this study. Firstly, 
focusing on a mildly symptomatic patient group who 
are largely excluded from other trials provided novelty 
and potential for clinical benefit. We used a multicentre 
study design incorporating a large sample of practices 
representative of the general UK population; a 
pragmatic design to accommodate a broad patient 
group with no selection by motivation to change health 
behaviours; spirometry was undertaken using trained 
staff and quality assured and we achieved a good 
follow-up rate. The intervention was underpinned by 
social cognitive theory and included techniques such 
as goal setting that have been shown to be effective in 
modifying behaviour and was at an intensity that might 
potentially be delivered in a publicly funded health 
service.46 We achieved good fidelity of delivery of the 
intervention, with 75% of intervention participants 
receiving all four calls and only four patients receiving 
none. There did not appear to be any contamination or 
change in behaviour in the usual care group with their 
self reported self management behaviours remaining 
static throughout the trial. In keeping with the 
pragmatic nature of this intervention, we did not check 
whether those who checked inhaler use technique 
had adequate training, but this is a core component of 
primary care management of COPD.24T
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Our study has some limitations. The intervention 
was in a group of people with only mild symptoms 
of breathlessness, who may not have considered 
themselves ill, thus a high degree of motivation may 
have been needed to take part. Highly motivated 
patients would be more likely to self manage their 
condition and change lifestyle behaviours. Our 
sample reported high levels of regular physical activity 
exceeding the lower recommended amount of moderate 
or vigorous activity per week at baseline; so, despite 
our efforts to recruit all eligible patients from primary 
care there is likely to have been self selection of people 
to the study, which may have affected capacity to 
improve, which is a feature of most behaviour change 
trials. The intervention did not meet the needs of some 
patients who withdrew from the intervention and in 
some cases also withdrew from the trial, resulting in 
an imbalance in follow-up rates between study arms. 
The patients who withdrew gave reasons including 
feeling that the intervention did not meet their needs 
as they were already physically active and some that 
were too unwell after an exacerbation. This may point 
to the need for more individual tailoring than actually 
occurred. In addition, delivery by telephone may give 
less opportunity for the building of rapport between 
the patient and nurse. Issues of rapport, acceptability, 
and tailoring of the intervention will be addressed in 
more detail in a separate publication of the qualitative 
evaluation. We did not observe large differences in the 
characteristics of those who withdrew from the trial, 
nor any differences in the interpretation of the primary 
outcome with a sensitivity analysis to assess the impact 
of missing data. The power calculation was based on 
detecting a four point difference in the SGRQ-C at 12 
months (mean score 39, SD 15). Although participants 
in patient self management COPD had less severe 
disease at baseline (mean score 28.7) than expected, 
the standard deviation was 14.5 meaning we still 
have 80% power to detect the four point difference. 
However, owing to the lower SGRQ-C score at baseline, 
this four point difference now corresponds to a 14% 
proportional reduction compared with the 10% 
proportional reduction in the original sample size.
We trained the nurses for two days with further role 
plays and group calls to discuss challenges once the 
intervention had started. Our evaluation of the logs 
of their telephone calls and recorded calls identifies 
a variation in communication style from a patient 
centred to a more directive approach. Further, owing 
to the nature of recruitment across different sites, the 
distribution of calls completed by nurses was uneven. 
It was apparent that some patients were reluctant to set 
physical activity goals. It is possible that longer nurse 
training would have led to greater communication 
skills and more behavioural change, but this was a 
pragmatic study that aimed to evaluate an intervention 
that could be rolled out in practice. It is possible that a 
longer intervention duration, with calls beyond three 
months, would have led to greater effects and that in 
our group with predominantly mild disease, follow-up 
beyond 12 months might be needed to detect changes.
Implications for clinicians and policy makers
Adding telephone health coaching to support self 
management did not improve health related quality of life 
in our patient population with only mildly symptomatic 
disease and who were already quite physically active 
at baseline. It did, however, lead to an increase in self 
reported physical activity at six months, which is likely 
to result in health benefits,15 16 and self management 
activities which are likely to reduce the frequency and 
severity of exacerbations. While there is still uncertainty 
about best practice for managing people with mildly 
symptomatic disease, inhaled therapies are widely 
used in this group and improved engagement with 
education about correct delivery technique will help to 
realise improved outcomes for these patients.18 19 Self 
management support is currently recommended, but it 
is not likely to be well implemented.47 Much evidence 
for COPD self management support comes from patients 
recruited from secondary care and there needs to be a 
synthesis of the findings of support for self management 
in patients recruited from a primary care setting. It may 
be that among people with mildly symptomatic disease, 
self management support should be provided for those 
with poorest health related quality of life, which is the 
greatest predictor of future quality of life,48 or in those 
with the most frequent exacerbations.14 It may also be 
that a different health related quality of life outcome 
measure is needed for people with mild or early COPD 
that addresses limitations specific to the stage of their 
disease.
There is a lack of evidence of effective interventions 
for patients with mild COPD and this trial, while 
improving some self management behaviours, did 
not show evidence of clinical benefit. There remains a 
need to identify successful interventions for patients 
with milder symptoms of COPD and this also has clear 
implications for screening or case finding activities, 
which would identify patients with mild disease, and 
cannot be recommended while there is a lack of effective 
treatment options for this patient group. There are wider 
implications in the use of telephone health coaching; a 
rapid review reported that it appears to be most effective 
in vulnerable populations, who have difficulty accessing 
health services,4 which is not reflective of our study 
population. Supporting self management in patients 
with early disease, or risk factors, remains a challenge. 
Apart from diabetes prevention programmes, health 
services generally focus self management support and 
rehabilitation services on people with more advanced 
disease, but there is the potential for considerable 
health and health service gains if we could facilitate self 
management in patients with early disease and slow 
their decline. Establishing whether this is possible will 
require long term follow-up studies.
Conclusions and policy implications
A novel telephone health coaching intervention to 
promote behaviour change in patients with mild 
symptoms of dyspnoea in primary care led to changes 
in self management activities, but did not improve 
health related quality of life. There remains a clear 
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need to identify risk mitigating interventions that can 
effectively prevent or delay disease progression in this 
patient group.
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